EAGAN, Minn.--(BUSINESS WIRE)--Ada Braun, M.D., Ph.D., Chief Medical Officer for Biothera’s Pharmaceutical business, will participate in an expert panel discussion of novel immunomodulatory therapies tomorrow at the 26th Annual Cancer Progress Conference in New York, NY.
“Immunotherapy I: Targeting Checkpoint, Co-Stimulatory and Novel Immunomodulatory MOAs” The panel will include leading clinicians and researchers from major pharmaceutical companies focused on new therapies that engage the immune system to fight cancer.
Help employers find you! Check out all the jobs and post your resume.
“Immunotherapy I: Targeting Checkpoint, Co-Stimulatory and Novel Immunomodulatory MOAs” The panel will include leading clinicians and researchers from major pharmaceutical companies focused on new therapies that engage the immune system to fight cancer.
Help employers find you! Check out all the jobs and post your resume.
